Efficacy, Safety, Pharmacokinetics of ICP-488 in Patients With Moderate to Severe Plaque Psoriasis

NCT06842199 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

383

Enrollment

INDUSTRY

Sponsor class

Conditions

Plaque Psoriasis Patients

Interventions

DRUG: ICP-488 Tablets
DRUG: ICP-488 Placebo

Sponsor

Beijing InnoCare Pharma Tech Co., Ltd.